Andrew J. Fromkin Immunovant, Inc. (IMVT) insider trading activity

Andrew J. Fromkin is Director of Immunovant, Inc.. Currently has a direct ownership of 108,101 shares of IMVT, which is worth approximately $2.97 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 16,188 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K

8.2% 3M change

8.2% 12M change

Total Value Held $2.97 Million

Andrew J. Fromkin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	BUY Grant, award, or other acquisition	-	16,188 Added 13.02%	108,101 Common Stock
Mar 07 2025	SELL Open market or private sale	$157,920 $19.74 p/Share	8,000 Reduced 8.01%	91,913 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	11,255 Added 10.12%	99,913 Common Stock
Dec 01 2023	SELL Open market or private sale	$490,048 $39.68 p/Share	12,350 Reduced 12.23%	88,658 Common Stock
Apr 12 2023	BUY Grant, award, or other acquisition	-	12,523 Added 11.03%	101,008 Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	21,059 Added 19.22%	88,485 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	-	21,726 Added 24.37%	67,426 Common Stock
Aug 10 2021	BUY Open market or private purchase	$43,450 $7.9 p/Share	5,500 Added 10.74%	45,700 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	15,500 Added 27.83%	40,200 Common Stock

AJF

Andrew J. Fromkin

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Value

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT

Account